Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 366

1.

A practical guide to assess the Nancy histological index for UC.

Marchal-Bressenot A, Scherl A, Salleron J, Peyrin-Biroulet L.

Gut. 2016 Aug 26. pii: gutjnl-2016-312722. doi: 10.1136/gutjnl-2016-312722. [Epub ahead of print] No abstract available.

PMID:
27566129
2.

Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis.

Peyrin-Biroulet L, Germain A, Patel AS, Lindsay JO.

Aliment Pharmacol Ther. 2016 Aug 17. doi: 10.1111/apt.13763. [Epub ahead of print] Review.

PMID:
27534519
3.

Patient reported-outcomes in a French nationwide survey of inflammatory bowel disease patients.

Williet N, Sarter H, Gower-Rousseau C, Adrianjafy C, Olympie A, Buisson A, Beaugerie L, Peyrin-Biroulet L.

J Crohns Colitis. 2016 Aug 11. pii: jjw145. [Epub ahead of print]

PMID:
27516406
4.

Ulcerative proctitis is a frequent location of paediatric-onset UC and not a minor disease: a population-based study.

Hochart A, Gower-Rousseau C, Sarter H, Fumery M, Ley D, Spyckerelle C, Peyrin-Biroulet L, Laberenne JE, Vasseur F, Savoye G, Turck D; Epimad Group.

Gut. 2016 Aug 3. pii: gutjnl-2016-311970. doi: 10.1136/gutjnl-2016-311970. [Epub ahead of print]

PMID:
27489240
5.

Patient Perspectives on Biosimilars: A Survey by the European Federation of Crohn's and Ulcerative Colitis Associations.

Peyrin-Biroulet L, Lönnfors S, Roblin X, Danese S, Avedano L.

J Crohns Colitis. 2016 Jul 31. pii: jjw138. [Epub ahead of print]

PMID:
27481878
6.

Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.

Cheddani H, Dauchet L, Fumery M, Charpentier C, Marie Bouvier A, Dupas JL, Pariente B, Peyrin-Biroulet L, Savoye G, Gower-Rousseau C.

Am J Gastroenterol. 2016 Aug 2. doi: 10.1038/ajg.2016.304. [Epub ahead of print]

PMID:
27481308
7.

Editorial Personalized Medicine in Inflammatory Bowel Diseases: Myth or Reality?

Peyrin-Biroulet L, Danese S.

Curr Drug Targets. 2016 Jul 13. [Epub ahead of print] No abstract available.

PMID:
27469468
8.

An index with improved diagnostic accuracy for the diagnosis of Crohn's disease derived from the Lennard-Jones criteria.

Reinisch S, Schweiger K, Pablik E, Collet-Fenetrier B, Peyrin-Biroulet L, Alfaro I, Panés J, Moayyedi P, Reinisch W.

Aliment Pharmacol Ther. 2016 Sep;44(6):601-11. doi: 10.1111/apt.13727. Epub 2016 Jul 28.

PMID:
27466047
9.

The Crohn's Disease-Ulcerative Colitis Clinical Appraisal Update: Emerging Trends in Clinical Practice.

Sandborn W, Colombel JF, D'Haens G, Ghosh S, Panaccione R, Panés J, Travis S, Peyrin-Biroulet L.

Clin Gastroenterol Hepatol. 2016 Sep;14(9):e121-2. doi: 10.1016/j.cgh.2016.07.008. Epub 2016 Jul 25. No abstract available.

10.

Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease.

Peyrin-Biroulet L, Van Assche G, Gómez-Ulloa D, García-Álvarez L, Lara N, Black CM, Kachroo S.

Clin Gastroenterol Hepatol. 2016 Jul 5. pii: S1542-3565(16)30372-X. doi: 10.1016/j.cgh.2016.06.025. [Epub ahead of print] Review.

PMID:
27392760
11.

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease.

Pouillon L, Bossuyt P, Peyrin-Biroulet L.

Expert Opin Biol Ther. 2016 Jul 4:1-14. [Epub ahead of print]

PMID:
27329436
12.

Cancer and inflammatory bowel disease in the elderly.

Taleban S, Elquza E, Gower-Rousseau C, Peyrin-Biroulet L.

Dig Liver Dis. 2016 May 20. pii: S1590-8658(16)30423-6. doi: 10.1016/j.dld.2016.05.006. [Epub ahead of print] Review.

PMID:
27289334
13.

Evolving treatment algorithms in Crohn's Disease.

Wisniewski A, Danese S, Peyrin-Biroulet L.

Curr Drug Targets. 2016 Jun 6. [Epub ahead of print]

PMID:
27280794
14.

What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?

Conroy G, Clerc-Urmès I, Allen PB, Baumann C, Peyrin-Biroulet L.

Inflamm Bowel Dis. 2016 Jul;22(7):E25-6. doi: 10.1097/MIB.0000000000000837. No abstract available.

PMID:
27271494
15.

Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study.

Danese S, Hart A, Dignass A, Louis E, D'Haens G, Dotan I, Rogler G, D'Agay L, Iannacone C, Peyrin-Biroulet L.

BMJ Open Gastroenterol. 2016 May 17;3(1):e000092. doi: 10.1136/bmjgast-2016-000092. eCollection 2016.

16.

Biologic therapies in ulcerative colitis: primi inter pares?

Allocca M, Fiorino G, Gilardi D, Preatoni P, Papa A, Peyrin-Biroulet L, Danese S.

Curr Drug Targets. 2016 May 27. [Epub ahead of print]

PMID:
27231106
17.

Diagnostic Delay Is Associated with a Greater Risk of Early Surgery in a French Cohort of Crohn's Disease Patients.

Nahon S, Lahmek P, Paupard T, Lesgourgues B, Chaussade S, Peyrin-Biroulet L, Abitbol V.

Dig Dis Sci. 2016 May 20. [Epub ahead of print]

PMID:
27207180
18.

Natural History of Crohn's Disease in Elderly Patients Diagnosed Over the Age of 70 Years: A Population-Based Study.

Fumery M, Pariente B, Sarter H, Charpentier C, Armengol Debeir L, Dupas JL, Coevoet H, Peyrin-Biroulet L, dʼAgay L, Gower-Rousseau C, Savoye G; EPIMAD group.

Inflamm Bowel Dis. 2016 Jul;22(7):1698-707. doi: 10.1097/MIB.0000000000000821.

PMID:
27206018
19.

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

Bonovas S, Fiorino G, Allocca M, Lytras T, Nikolopoulos GK, Peyrin-Biroulet L, Danese S.

Clin Gastroenterol Hepatol. 2016 May 14. pii: S1542-3565(16)30197-5. doi: 10.1016/j.cgh.2016.04.039. [Epub ahead of print]

PMID:
27189910
20.

French national consensus clinical guidelines for the management of ulcerative colitis.

Peyrin-Biroulet L, Bouhnik Y, Roblin X, Bonnaud G, Hagège H, Hébuterne X; gastroenterologist nominal group.

Dig Liver Dis. 2016 Jul;48(7):726-33. doi: 10.1016/j.dld.2016.03.029. Epub 2016 Apr 11.

PMID:
27158125
Items per page

Supplemental Content

Loading ...
Write to the Help Desk